share_log

iBio Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals

iBio Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals

iBio Inc | SC 13G：超過5%持股股東披露文件
SEC announcement ·  04/09 08:23
牛牛AI助理已提取核心訊息
On March 28, 2024, Opaleye Management Inc. filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in iBio Inc. The filing revealed that Opaleye Management holds 650,000 shares of iBio Inc., which represents 7.63% of the company's issued and outstanding common stock. The shares are reported to have shared voting and dispositive power. This disclosure is based on the number of shares outstanding as reported by iBio Inc. on its Form 10-Q filed with the SEC on April 1, 2024. The filing by Opaleye Management, a Massachusetts-based entity, is a routine regulatory requirement indicating ownership exceeding five percent of a company's shares and does not necessarily suggest an intention to influence or change the control of iBio Inc.
On March 28, 2024, Opaleye Management Inc. filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in iBio Inc. The filing revealed that Opaleye Management holds 650,000 shares of iBio Inc., which represents 7.63% of the company's issued and outstanding common stock. The shares are reported to have shared voting and dispositive power. This disclosure is based on the number of shares outstanding as reported by iBio Inc. on its Form 10-Q filed with the SEC on April 1, 2024. The filing by Opaleye Management, a Massachusetts-based entity, is a routine regulatory requirement indicating ownership exceeding five percent of a company's shares and does not necessarily suggest an intention to influence or change the control of iBio Inc.
2024年3月28日，Opaleye Management Inc.向美國證券交易委員會（SEC）提交了附表13G，表示擁有iBio Inc.的大量所有權。該文件顯示，Opaleye Management持有iBio Inc.的65萬股股份，佔該公司已發行和流通普通股的7.63％。據報道，這些股票具有共同的投票權和處置權。該披露基於iBio Inc.在2024年4月1日向美國證券交易委員會提交的10-Q表中報告的已發行股票數量。總部位於馬薩諸塞州的實體Opaleye Management提交的文件是一項例行監管要求，表明所有權超過公司股份的5％，並不一定表示有意影響或改變iBio Inc的控制權。
2024年3月28日，Opaleye Management Inc.向美國證券交易委員會（SEC）提交了附表13G，表示擁有iBio Inc.的大量所有權。該文件顯示，Opaleye Management持有iBio Inc.的65萬股股份，佔該公司已發行和流通普通股的7.63％。據報道，這些股票具有共同的投票權和處置權。該披露基於iBio Inc.在2024年4月1日向美國證券交易委員會提交的10-Q表中報告的已發行股票數量。總部位於馬薩諸塞州的實體Opaleye Management提交的文件是一項例行監管要求，表明所有權超過公司股份的5％，並不一定表示有意影響或改變iBio Inc的控制權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。